Subscribe to Receive the Daily Report

Thursday, May 9th, 2019

This polling reveals how pharmaceutical companies have distorted Congress — and ripped off the country

Author:     Alex Lawson and Stephanie Taylor
Source:     Alternet
Publication Date:     May 6, 2019
 Link: This polling reveals how pharmaceutical companies have distorted Congress — and ripped off the country
Stephan:   Prescription drug spending per capita is far higher in the United States than in the nine other high-income countries studied by the Commonwealth Fund. For instance, insulin that is $16 in Italy can be $1500 in the U.S.. American drug prices are absurd, and we are one of the most over medicated nations in the world. This is one of the worst aspects of the American illness profit system. Here is some background information.

It doesn’t matter where you live in this country or what your political identification is; nobody likes getting ripped off by pharma. Everybody wants their members of Congress to drastically lower drug prices by taking on big pharma’s greed and breaking up pharmaceutical monopolies.

Our organizations, Social Security Works and the Progressive Change Campaign Committee, recently commissioned new polling by Public Policy Polling that shows that lowering drug prices is not a partisan issue. Republicans, Democrats and Independents overwhelmingly agree that Congress must act aggressively to lower drug prices. The only people who don’t want bold, aggressive action are the drug corporations and the members of Congress who are listening to them instead of their constituents.
Public Policy Polling surveyed Americans in three House districts—Iowa’s 4th, represented by Republican Steve King; New Hampshire’s 1st, represented by Democrat Chris Pappas; and South Carolina’s 1st, represented by Democrat Joe Cunningham. These are all swing, frontline congressional districts, the kind where both parties worry most about winning control. They are all also in early caucus or primary states for the 2020 presidential races. Together […]

Read the Full Article

1 Comment